Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Compositions and methods for identification, assessment, prevention, and treatment of AML using USP10 biomarkers and modulators

Compositions and methods for identification, assessment, prevention, and treatment of AML using USP10 biomarkers and modulators

US Patent 11136409 · Granted Oct 5, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

USP7 inhibition2025
Methods to treat lymphoplasmacytic lymphoma2024
USP7 inhibitors for treating multiple myeloma2022
Compounds for the degradation of STK4 and treatment of hematologic malignancies2022
Antifungal compounds and uses thereof2021
Inhibitors of interleukin-1 receptor-associated kinases and uses thereof2021
Thiazolyl-containing compounds for treating proliferative diseases2020
STK4 inhibitors for treatment of hematologic malignancies2020
Methods to treat lymphoplasmacytic lymphoma2020
Methods to treat lymphoplasmacytic lymphoma2020
HCK as a therapeutic target in MYD88 mutated diseases2020
Thiazolyl-containing compounds for treating proliferative diseases2019